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Abstract: Analysis of pathogen genome data sequenced from clinical and historical samples has
made it possible to perform phylogenetic analyses of sexually transmitted infections on a global
scale, and to estimate the diversity, distribution, and coevolutionary host relationships of these
pathogens, providing insights into pathogen emergence and disease prevention. Deep-sequenced
pathogen genomes from clinical studies and ancient samples yield estimates of within-host and
between-host evolutionary rates and provide data on changes in pathogen genomic stability and
evolutionary responses. Here we examine three groups of pathogens transmitted mainly through
sexual contact between modern humans to provide insight into ancient human behavior and history
with their pathogens. Exploring ancient pathogen genomic divergence and the ancient viral-host
parallel evolutionary histories will help us to reconstruct the origin of present-day geographical
distribution and diversity of clinical pathogen infections, and will hopefully allow us to foresee
possible environmentally induced pathogen evolutionary responses. Lastly, we emphasize that
ancient pathogen DNA research should be combined with modern clinical pathogen data, and be
equitable and provide advantages for all researchers worldwide, e.g., through shared data.
Keywords: evolutionary medicine; sexually transmitted infections; papillomaviruses; herpesviruses;
ectoparasites; virus-host coevolution; divergence; host-switch; Hominin evolution
1. Introduction
Every human carries infectious agents during their lifetime, including sexually transmitted
microbes. Accumulating viral pathogen genome data sequenced from clinical samples has made
it possible to infer phylogenetic analysis of sexually transmitted infections on a global scale and to
estimate the diversity and distribution of these pathogens, and their common evolutionary histories
with their host [1,2]. In parallel, high throughput sequencing technologies, along with sequence
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capture enrichment methods, have made the analysis of ancient genetic material possible through the
retrieval of endogenous human and pathogen DNA from ancient samples [3–5].
Viruses and other pathogens commonly spread through anogenital or oral contact have a long-standing
association with humans. Most of these sexually transmitted pathogens, either as persistent or acute
infections [6], are carried through life. They mostly mutate slowly and spread mainly from person to person
through sexual contact [7,8]. Although mammalian reproductive behaviors can be quite complex, it is
commonly assumed that human sexual behaviors are ubiquitous [9,10]. Therefore, it is very likely that
archaic hominins carried several sexually transmitted infections (STIs), and some of them were inherited
from their ancestors [1,11–13]. Nevertheless, a note of caution is needed as nonsexual transmission of
modern STIs may have played a role in ancient pathogen transmission.
The analysis of pathogen genome diversity provides significant insights into pathogen emergence
and disease prevention [14]. Using deep-sequenced pathogen genomes retrieved from clinical studies [2],
it is possible to estimate the within-host and between-host evolutionary rates, and to understand the
changes in genomic stability and evolutionary responses for a particular pathogen [15]. Furthermore,
applying substitution rates in ‘measurably evolving’ pathogen genome data [16] enables the generation
of the minimum divergence time estimate of the pathogen [17]. Subsequently, the population’s genetic
structure provides data on the population structure of the virus [18], and the host, if codivergence is
assumed [14]. Thus, particular pathogens hold complementary stories about human evolutionary history.
The genomes of slowly evolving STIs may even help us to understand when and where hominins had
sex, as not all sexual interactions led to successful interbreeding.
Recently retrieved hominin fossils [19–21] and ancient hominin genomes [22–24] have transformed
our view of human evolution over the last 500,000 years by revealing that our modern human ancestors
formed part of a network of archaic hominin populations linked by significant, although fluctuating,
gene flow (Figure 1) [25]. The evolutionary relationship is still unclear between our closest archaic and
modern human relatives (i.e., Denisovans, Neanderthals, and archaic Africans) and the time frame
of their likely introgression within the African archaic hominin metapopulation, including modern
human ancestors [21,25–27]. In this context, we still have enormous gaps in our understanding not
only of archaic African human dispersals, but also the origins and impact of infectious diseases on
human evolution in Africa before modern human ‘Out-of-Africa’ migrations [21,28].
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Figure 1. Hominin host-switch model (modified from [1]). Schematic diagram of the pathogen
evolution and distribution out-of-Africa with the corresponding ancestral hominin group. Since the
migration of modern human ancestors to Eurasia 120,000–60,000 years ago, sexual transmission from
Neanderthals, Denisovans, or other hominin groups (i.e., introgression and pathogen host-switch)
likely introduced certain human papillomavirus, herpesvirus, and ectoparasitic pathogens to the
arriving group of modern human ancestors in Eurasia.
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The emergence of hominins in Africa was influenced by the diversity and wide distribution of
human pathogens [29,30]. From the total of 1415 human pathogens known today, 61% are zoonotic
and 175 cause infectious diseases, several of which originate from Africa [29–35]. In particular,
these ancient African pathogens share the longest common evolutionary history with hominins prior
to their out-of-Africa migrations, and thus presumably constrained the hominin populations already
in Africa [29–31,33–36]. Such patterns of pathogen-stress constraining the host population has been
observed in hunter-gatherer populations in sub-Saharan Africa [34,35,37–40].
This new understanding of a more complex human evolutionary history challenges prevailing
epidemiological hypotheses that human infectious diseases only started to severely impact humans
after the emergence of agriculture and sedentary lifestyles [33,41]. Instead, it advocates an ancient
pathogen origin and transmission scenario, including host-switch events typical of pathogen evolution,
between ancestral hominin groups and the African great apes (Figure 2) [1,12,42–47].
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Figure 2. Human pathogen origin and transmission scenario between modern human ancestors,
other hominin groups, and the African great apes. (a) Schematic diagram as a function of time (x-axis)
of the human pathogen presence originating from Africa (e.g., human papillomavirus (HPV), herpes
simplex virus (HSV), and human immunodeficiency virus (HIV) [29,30,33] depicted in green) and evolving
among modern humans migrating out-of-Africa (red color), with additional transmission between modern
humans and other hominins in Eurasia (e.g., HPV [1], HSV [42], lice [44], and bed bugs depicted as three
icons and subsequent prevalence in blue color). Hence, we highlight that, following the out-of-Africa
migration of modern humans, sexual transmission from Neanderthals or other hominin groups likely
introduced certain HPV, HSV, and ectoparasitic pathogens to modern humans, many of which are still
prevalent today. (b) The majority of modern human pathogens emerged in Africa (illustrated as green
shades along the corresponding Hominin and great ape evolutionary tree [29,30,33]), where they were
transmitted between ancestral hominin groups and the African great apes, and further codiverged and
dispersed outside Africa with the corresponding ancestral hominin groups: evolution of Neanderthal and
Denisovan populations exclusively in Eurasia with their corresponding pathogens (illustrated in blue color
and with three icons ca. 800–400 kya [48–51]), also leading to host-switch events with modern human
ancestors after modern human out-of-Africa migration and admixture, ca. 120–60 kya [48,49]. Pathogens
associated with modern humans outside Africa are illustrated in blackshades along the corresponding
modern human dispersals. Hominin evolution with wavy branch edges indicating presumed population
fluctuations in time was modified from [52].
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Molecular analytical techniques are increasingly applied to the field of pathogen ancient DNA
(aDNA), and the results contribute significantly to our understanding of prehistoric epidemiology [53–55].
For example, given the ambiguities involved in assigning Mycobacterium tuberculosis or Brucella melitensis
as causative agents of macromorphological skeletal features, the biomolecular (DNA) analysis of
archaeological human remains has gained increasing recognition [17,56].
Here we examine questions related to three groups of pathogens transmitted mainly through
sexual contact between modern humans, which are likely to provide insight into ancient human
behavior and history. We especially focus on the Papillomaviridae, Herpesviridae, and ectoparasitic
pathogen families.
2. Human Papillomaviruses
Papillomaviruses (PVs) are a diverse family of double-stranded DNA viruses with maybe
500 million years of common evolutionary history with vertebrates [57,58]. More than 350 PVs
have been identified from a range of host species, from fish to mammals, and over 200 of them are
human papillomaviruses (HPVs) [58,59]. Based on host resources [60], the evolution of mammalian
PVs started with environmentally-directed diversification and resulted in a few viral crown groups
associated with the evolution of mammalian fur and skin glands [61,62]. Subsequently PV evolution
was driven by the codivergence with the mammalian adaptive radiation, however, incomplete lineage
sorting and host-switch events leading to lost or newly distributed lineages, respectively, also played
a significant role in the evolution of PVs [47,57,63,64]. Assuming limited virus-host coevolution,
the evolutionary rate for PVs has been estimated around 10 8 substitutions per site per year [57,65].
This fits our knowledge of PV lifestyle, as PVs do not encode for DNA polymerases and resort instead
for replication to high-fidelity host nuclear polymerases [66]. However, these rate estimates should be
interpreted with caution because a priori assuming host-pathogen codivergence as a leading drive of
PVs evolution might lead to factitious estimates as demonstrated for human polyomaviruses [67].
HPVs infect basal epithelial cells at the cutaneous and mucosal sites, and a fraction of some
50 HPVs are found in the genital tract [68]. These HPVs are the most common sexually transmitted
infections in humans, and practically all sexually active individuals become infected by a number of
anogenital HPVs. Fortunately, most sexually transmitted HPV infections remain asymptomatic and
are cleared by the host immune system [69]. Prevalence of these transient HPV infections is estimated
at 12% in healthy women worldwide [70]. However, a persistent anogenital infection by a subset of at
least twelve oncogenic HPVs is associated with the development of genital and anal cancers [68].
HPVs have coexisted with humans since the origin of our species, and with variable
clinical manifestations, the globally circulating HPV population has been largely shaped by host
population-level processes [14,71]. The continuous interplay with the differential host immune
response among humans has likely further constrained the population structure of the HPVs [14]. It was
previously assumed that HPVs coevolved exclusively among modern humans, but recent work using
Bayesian phylogenetic inference suggests that HPVs evolved separately within each archaic hominin
population, and subsequent interbreeding between Neanderthals and ancestral modern humans led to
pervasive host-switching of HPVs (Figure 1) [1]. A comprehensive HPV16 phylogeography reveals
a clear geographic structure and a deep split between the two main HPV16 lineages (HPV16A and
HPV16BCD) [1]. Testing the two opposing models, the recent-out-of-Africa and Hominin-host-switch
models, for HPV16 coevolution showed that codivergence exclusively with modern humans explains
at most 30% of the observed global HPV16 diversity distribution. Instead, the most likely explanation
of the deep HPV16 divergence and phylogeography was the Hominin-host-switch model (Figure 1),
which required the basal HPV16A lineage transmission from archaic to modern humans after their
migration to Eurasia [1].
These findings could explain an unusual aspect of HPV genetic diversity: why is the HPV16A variant
virtually absent in sub-Saharan Africa when it is the most common outside Africa? Collectively, all ancestral
hominin populations in Africa were likely infected by similar archaic HPVs. Hence, when Neanderthal and
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Denisovan populations evolved in Eurasia some 400,000–800,000 years ago, they initially carried a similar
archaic collection of HPV16 diversity as their archaic contemporaries, but which subsequently evolved into
a distinct collection of Neanderthal/Denisovan HPV16 variation, and ultimately led to the HPV16A lineage
(see also Figure 2).
When the ancestors of modern humans migrated out of Africa some 60,000–120,000 years ago,
they carried their HPV16 diversity, namely the HPV16BCD lineages, which initially evolved among
modern human ancestors in Africa. Repeated interbreeding between Neanderthals and modern
human ancestors in Eurasia transmitted the HPV16A lineage from archaic populations to modern
human ancestors [1]. Furthermore, a subsequent study of oncogenic HPV58 diversity concluded
the Hominin-host-switch model was the most likely explanation for the deep HPV58 divergence [46].
An additional evaluation, however, for the HPV58 phylogenetic inference may be needed as neither
the effect of natural selection nor divergence model were comprehensively tested [72,73].
To independently explore ancient HPV diversity patterns, including divergence in evolutionary
timescales, requires the retrieval of endogenous HPV DNA from ancient tissue samples. Pimenoff and
colleagues [1] examined available archaic hominin preassembly sequence data, but no endogenous
HPV DNA was retrieved. HPVs exclusively infect basal epithelia that are not likely to be preserved
in ancient bone samples. Cutaneous epithelia-infecting HPVs are naturally present in all of us and
typically found in most human metagenomic data [74]. It is theoretically possible, however, there seems
to be no evidence of HPV DNA with a clear ancient DNA decay pattern thus far, from ancient or
archaic human sample [75]. Likewise, a recent study claiming successful retrieval of 27,000 year old
rodent PV DNA critically needs further confirmation using deep sequencing [76].
To sequence HPV DNA from paleopathological samples, visible HPV-induced warts offer an
alternative. A recent study has reported the retrieval of short ~140bp DNA fragments of HPV18 from
a 16th century mummified wart sample [77]. However, caution is needed as the HPV18 sequences
retrieved were not published, and the result has not yet been confirmed. Future studies using aDNA
enrichment technology targeted for HPVs and applied to deep sequencing of well-preserved ancient
human tissue samples could enable an independent analysis of the deep coevolutionary patterns
of sexually transmitted HPV infections in humans. Also, future HPV genome sequencing from
nonvaccinated and vaccinated individuals worldwide with normal cytological findings will likely
reveal a more accurate estimate of the phylodynamics of HPVs in modern humans.
3. Human Herpesviruses
Herpesviruses are ancient, double-stranded DNA viruses with large genomes which infect
a range of metazoans, from corals to mammals [78,79]. Herpesviruses are associated with diverse
disease manifestations, from asymptomatic primary infection, to blistering and cancers. They are
predominantly spread through close physical contact and exchange of bodily fluids, including
breast-feeding and sexual intercourse [80–82].
With the increasing availability of whole herpesvirus genomes from humans and other
mammals [2,83–85], there is growing awareness that primate herpesviruses can illuminate hominin
evolution, particularly interactions between hominin species who may not be the direct ancestors
of living humans [43,83]. A study of chimpanzee simplex and human herpes simplex viruses
(HSV) 1 and 2 found that chimpanzee simplex and HSV1 cospeciated with their respective hosts.
HSV2, the aetiological agent of genital herpes in humans, originated as a cross-species transmission of
chimpanzee simplex into the human lineage millions of years after the divergence of the last common
ancestor of humans and chimpanzees [43]. Modelling suggests that HSV2 was transmitted from the
ancestors of chimpanzees to Homo erectus by Paranthropus boisei [42]. These inferences were drawn
from viruses collected from living primates, but our knowledge is incomplete and we do not currently
have access to sequences of the -herpesviruses which infect gorillas and bonobos. These may reveal
whether cross-species transmission of -herpesviruses is common amongst the great apes. Others have
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speculated that hominin-to-hominin transmission of a human -herpesvirus, varicella-zoster virus,
may have contributed to the extinction of the Neanderthals [86].
The HSV2 cross-species transmission event probably took place 2 mya, beyond the current
event horizon for aDNA preservation in even the most favorable conditions. Furthermore, human
-herpesviruses are not oncogenic and would not preserve in tumor samples, although preserved oral
soft tissue samples or blood within teeth from more recently deceased humans could be a source of
-herpesvirus aDNA.
There are a number of questions concerning the evolution of the first oncogenic human virus to
be identified, Epstein-Barr virus (EBV) [87], and related oncogenic human -herpesvirus KSHV [88].
EBV is grouped into two types, 1 and 2 [89], with genotypic and phenotypic differences in latency
associated genes (EBNAs) which are key for the virus’ persistence within the host following primary
infection [87,90]. Differences within EBNA genes are also associated with differences in tropism
between type 1 (B cells) and type 2 (T cells [91]) EBV. It is currently unknown when EBV types 1
and 2 diverged. Differences beyond the known EBNA-2 and EBNA-3A/B/C cluster are not linked
to EBV type, pointing to a common origin for the rest of the EBV genome as a single species [89].
The divergence of type 1 and 2 EBNA gene clusters may be linked to human evolutionary history,
given the lower prevalence and differing distribution of type 2 outside Africa [92]. Evidence for
cross-species transmission and recombination in the KSHV genome [93] raises the possibility that
EBV may also have an unusual evolutionary history. Modern clinical sequence data could address
this by providing more sequences from modern and historical African samples [2] for evolutionary
analysis [1,94]. There is scope for aDNA to answer these questions. As both human -herpesviruses are
oncogenic, metastatic EBV or KSHV+ tumors would be macroscopically visible as skeletal pathology
in the form of neoplastic lesions in the osteogenic mesenchyme and contain copies of the integrated
viral DNA within the tumor cells. Mummified human remains are another potential source, as is
dental pulp [95].
4. Human Ectoparasites
One of the most challenging aspects of understanding ancient human health is determining when
diseases emerged and how they spread. Haematophagous ectoparasitic arthropods (e.g., lice and bedbugs)
are among the oldest human parasites and, being dependent on their human hosts for mobility, represent
excellent markers of ancient human migrations. As vectors of lethal pathogens, including epidemic
typhus (Rickettsia prowazekii), trench fever (Bartonella quintana), and relapsing fever (Borrelia recurrentis),
lice and bedbugs are of medical importance. Indeed, resembling ancient human dispersal patterns [96],
molecular analyses of microbial pathogens [34,35] support a serial founder effect model out-of-Africa.
Similarly, conspecific human parasites (e.g., human lice) have been used to trace the migration of humans
from Africa and into the New World [97].
Humans are parasitised by two species of lice, pubic lice, Pthirus pubis, and head and body
lice, Pediculus humanus. Human pubic or ‘crab’ lice share many morphological similarities and
a most recent common ancestor with the gorilla louse, Pthirus gorillae. Based on mitochondrial DNA
(mtDNA) sequence data, P. gorillae and P. pubis are estimated to have diverged some 3.3 mya [98].
As the Pthirus life cycle does not include a free-living phase, the Pthirus host species transfer implies
spatio-temporal overlap and close physical contact between hominins and ancestral gorillas. At this
time, the sub-Saharan African rainforest margins were inhabited by at least three candidate species of
ancestral humans which could have facilitated the transfer of P. pubis to either H. habilis or H. erectus.
While the appearance of Australopithecus africanus at ca. 3.0 mya might represent a good fit for the
estimated divergence date of c. 3.3 mya, the presence of Australopithecus afarensis (from c. 3.9 to 2.8 mya)
at the margins of the African rainforests must also be considered. Once Pthirus reached H. erectus,
no further host-switches were required for Pthirus to continue its close association with hominins in
the lineage leading to modern H. sapiens.
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While human ectoparasites such as lice can survive for thousands of years in archaeological
contexts (e.g., [97]), morphological identification is problematic as remains are often highly fragmented.
The analyses of mitochondrial DNA of ancient head louse eggs from Israel suggests close affinities
with lice of people originating in west Africa [99]. In the near future, genome data derived from
ancient African contexts, in combination with probability-based network analysis [42], might provide
significant insight into the origins, transmission, and persistence of these undesirable passengers.
5. Ancient Pathogen DNA Prospects
Currently circulating viral and ectoparasitic diversity may only represent the most successful
or recent strains (strain replacement), which often capture a fraction of the genetic diversity of the
particular pathogen’s evolutionary history and can cause factitious divergence time estimates [100].
Recently sampled microorganisms may lack sufficient temporal structure and lead to spurious
evolutionary rate estimates [101]. Most importantly, molecular evolution rates are shown to be
time-dependent and without sufficient independent calibration points, which pathogen aDNA can
provide, within the time depths of the analysis the divergence time estimates can be systematically
overestimated [3,17,102–105]. However for some rapidly evolving viruses such as hepatitis B [106],
aDNA calibration points do not appear to improve the accuracy of estimates of the age of currently
circulating viral diversity [107]. Recent studies of HBV aDNA have produced conflicting results as to
whether molecular clock-based approaches to dating how long HBV has been a human pathogen are
suitable [106,108,109]. They have also emphasized the power of direct dating of HBV from ancient
human remains to demonstrate how long HBV has infected humans, its diversity and distribution in
past populations, and the possibility of transmission from nonhuman primates [108,109]. Another issue
in molecular dating of pathogen origins and divergence is cross-validation [110] to evaluate the
differential fit of the alternative models [72,111,112]. These studies further raise the prospect that HBV
may have been spread by nonsexual routes during the Pleistocene.
We consider that preserved anatomical specimens are an excellent source from which to extract
ancient pathogen DNA, particularly viruses and intracellular pathogens. Both disease lesions [113] and
cancer specimens [114] of increasing age have been successfully sequenced and have the scope to include
pathogen DNA. Museum collections also represent vital repositories of ancient host and pathogen
DNA [115–117]. If macroscopic samples of soft tissue or bone are not preserved, then sedimentary ancient
DNA can yield ancient pathogen DNA sequences. By employing the techniques of modern environmental
sampling [118] and skeletal aDNA analysis [23], ancient pathogen DNA can be successfully recovered
from coprolites [119], museum specimens [120], and prehistoric sediments [121–123].
6. Ancient DNA from Anthropogenic Sediments?
Environmental DNA (eDNA) is genetic material obtained from aquatic or terrestrial sediments and
marine or fresh water which do not contain identifiable biological source material [124]. In archaeology,
sedimentary analyses feature centrally in the establishment of relative and absolute chronologies [125],
with optically stimulated luminescence (OSL) dating being especially relevant in Pleistocene contexts [126].
Among other techniques traditionally used in archaeology, the microbial description of soils from
ancient (ca. 550 BC) homes in western Sicily suggests that ancient human activities can be mirrored
by specific activity-related soil microbial communities [127]. Evidence of past human behavior can be
found in microbiological residues in soil microbiota (e.g., bacterial and fungal aDNA) as a record of
anthropogenic modification.
In archaeological contexts, sedimentary ancient DNA (sedaDNA) occurs through the deposition of hair
and skin flakes, bodily fluids (i.e., urine, blood, etc.), and also via eggshells, insect exuviae, regurgitation
pellets, feathers, leaves, pollen, seeds, and living prokaryotes (through the secretion of plasmid and
chromosomal DNA) and viruses present within organic matter [118]. Sedimentary and environmental
samples have been a source for ancient viral [128], parasitic [129], and bacterial DNA [130,131].
Genes 2018, 9, 317 8 of 14
Ancient DNA has changed our view of human evolution, from our relationship with other
hominin groups (Neanderthals) and the existence of hominins that are difficult to analyze
phylogenetically because of limited or no fossils (Denisovans and yet unknown hominins in Africa,
respectively), to when and how different continents (Australasia, North and South America) were
populated. It is reasonable to suggest that ancient pathogen DNA will have a similar impact on
our view of the evolution of infectious diseases, with important implications for the prevention
of emerging pathogens. Exploring the boundaries of host-pathogen divergence, including the
maximum of pathogen divergence times in humans and nonhuman primates, and the ancient viral-host
parallel evolutionary histories will help us to reconstruct the origin of present-day geographical
distribution and diversity of clinical pathogen infections, and will hopefully allow us to foresee
possible environmentally induced pathogen evolutionary responses.
Finally, while Africa continues to play a crucial role in preserving our ancestors’ valuable but
limited paleontological and pathogen remains with the deepest evolutionary timescale, ancient DNA
sampling in Africa is dominated by well-funded foreign laboratories. In order to give African scholars
a role in the discovery and analysis of aDNA, a code of conduct to provide mutual collaborative
research support should be standard in ancient DNA research. Moreover, ancient pathogen DNA
research should be combined with modern clinical pathogen data and be equitable and provide
advantages for all researchers worldwide, e.g., through shared data. The Nagoya Protocol on access
to genetic resources and the fair and equitable sharing of benefits from the utility of such resources,
including traditional knowledge, is a promising international platform and guideline for ethical and
transparent benefit-sharing [132]. Moreover, it is encouraging to observe that research societies such as
the Society of Africanist Archaeologists [133] see these issues as important and consider ethics, history,
and the need for best practice in ancient DNA sampling for fruitful research and collaboration [134].
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